TED ROSENWASSER is a Partner of Trilantic North America and also a member of the Investment Committee. He primarily spends time on investments in the business services sector, with a focus on the healthcare end-markets. Ted joined Trilantic North America in 2014, prior to which he worked at Oak Hill Capital Partners in Menlo Park, CA. Ted also founded a health sciences startup, and earlier in his career, worked at Deutsche Bank Securities. He is currently a director of SOFIE Biosciences, Ingenovis Health, Rarebreed Veterinary Partners, and Taymax, and was formerly a director of Sunbelt Solomon and Home Franchise Concepts. Ted holds an M.B.A. from Columbia Business School and a B.A. in Information Science from Duke University.